drugset / Trial / NCT04100824

Stellate Ganglion Block as Adjuvant Therapy to ca Channel Blocker

NCT04100824

Phase 2 Completed 40 enrolled Assiut University
RandomizedParallel-groupQuadruple-blindPrevention

Summary

Aim of work: To evaluate the effect of stellate ganglion block in prevention of cerebrovascular spasm in traumatic subarachnoid hemorrhage Primary outcome: Asses changes of cerebral blood flow velocity by Trans cranial Doppler. Secondary outcome: Asses changes in clinical status

Timeline

Start
2020-01-11
Primary completion
2022-12-11
Completion
2023-01-12

Drugs

EvaluationDrugModalityDoseRoute
Background Nimodipine Small molecule 60 mg Oral